bunazosin has been researched along with Myocarditis in 2 studies
bunazosin: structure
Myocarditis: Inflammatory processes of the muscular walls of the heart (MYOCARDIUM) which result in injury to the cardiac muscle cells (MYOCYTES, CARDIAC). Manifestations range from subclinical to sudden death (DEATH, SUDDEN). Myocarditis in association with cardiac dysfunction is classified as inflammatory CARDIOMYOPATHY usually caused by INFECTION, autoimmune diseases, or responses to toxic substances. Myocarditis is also a common cause of DILATED CARDIOMYOPATHY and other cardiomyopathies.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Carvedilol, a nonselective beta-blocker with additional alpha1-adrenergic blocking and antioxidant properties, has been shown to be cardioprotective in experimental myocarditis." | 7.74 | Protective effects of carvedilol in murine model with the coxsackievirus B3-induced viral myocarditis. ( Ji-Fei, T; Jia-Feng, L; Jiang-Hua, R; Li-Sha, G; Peng, C; Peng-Lin, Y; Yue-Chun, L; Zhan-Qiu, Y, 2008) |
| "The purpose of this study was to investigate the therapeutic effect of an alpha 1-blocker, bunazosin, using an experimental murine model of congestive heart failure induced by viral myocarditis." | 7.68 | The effect of alpha 1-blocker, bunazosin on a murine model of congestive heart failure induced by viral myocarditis. ( Kawai, C; Matsumori, A; Okada, I; Tominaga, M; Yamada, T, 1992) |
| "Carvedilol, a nonselective beta-blocker with additional alpha1-adrenergic blocking and antioxidant properties, has been shown to be cardioprotective in experimental myocarditis." | 3.74 | Protective effects of carvedilol in murine model with the coxsackievirus B3-induced viral myocarditis. ( Ji-Fei, T; Jia-Feng, L; Jiang-Hua, R; Li-Sha, G; Peng, C; Peng-Lin, Y; Yue-Chun, L; Zhan-Qiu, Y, 2008) |
| "The purpose of this study was to investigate the therapeutic effect of an alpha 1-blocker, bunazosin, using an experimental murine model of congestive heart failure induced by viral myocarditis." | 3.68 | The effect of alpha 1-blocker, bunazosin on a murine model of congestive heart failure induced by viral myocarditis. ( Kawai, C; Matsumori, A; Okada, I; Tominaga, M; Yamada, T, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yue-Chun, L | 1 |
| Li-Sha, G | 1 |
| Jiang-Hua, R | 1 |
| Peng-Lin, Y | 1 |
| Jia-Feng, L | 1 |
| Ji-Fei, T | 1 |
| Peng, C | 1 |
| Zhan-Qiu, Y | 1 |
| Yamada, T | 1 |
| Matsumori, A | 1 |
| Okada, I | 1 |
| Tominaga, M | 1 |
| Kawai, C | 1 |
2 other studies available for bunazosin and Myocarditis
| Article | Year |
|---|---|
Protective effects of carvedilol in murine model with the coxsackievirus B3-induced viral myocarditis.
Topics: Acute Disease; Adrenergic beta-Antagonists; Animals; Anti-Inflammatory Agents; Antioxidants; Carbazo | 2008 |
The effect of alpha 1-blocker, bunazosin on a murine model of congestive heart failure induced by viral myocarditis.
Topics: Adrenergic alpha-Antagonists; Animals; Disease Models, Animal; Encephalomyocarditis virus; Enterovir | 1992 |